# A Phase 1a Study of PMN310 In Healthy Volunteers

> **NCT06105528** · PHASE1 · COMPLETED · sponsor: **ProMis Neurosciences, Inc** · enrollment: 40 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** PMN310
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06105528
- **Lead sponsor:** ProMis Neurosciences, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-11-18
- **Primary completion:** 2024-07-31
- **Final completion:** 2024-07-31
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2025-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06105528

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06105528, "A Phase 1a Study of PMN310 In Healthy Volunteers". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06105528. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*